Financhill
Sell
34

BIOLQ Quote, Financials, Valuation and Earnings

Last price:
$0.0100
Seasonality move :
-7.23%
Day range:
$0.0077 - $0.0150
52-week range:
$0.0040 - $0.2135
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
--
Volume:
33.5K
Avg. volume:
89.8K
1-year change:
-92.62%
Market cap:
$512.4K
Revenue:
$49.2M
EPS (TTM):
-$2.04

Earnings Data

Next earnings date for BIOLQ
Apr 04
2025
Most recent earnings per share
-$0.04
Missed by $0.04
(Nov 7/2024)
Consensus Estimate
--
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BIOLQ Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/28/2025 Q4 -- -- -- -- --
11/07/2024 Q3 -- $10.9M -$0.04 -- --
08/08/2024 Q2 $13.5M $11.6M -$0.08 -$0.01 -$0.07
03/31/2024 Q1 $10M $10.1M -$0.36 -$0.15 -$0.21
12/31/2023 Q4 $13.2M $13.5M -$1.56 -$0.90 -$0.66
09/30/2023 Q3 -- -- -$3.89 -$1.45 -$2.44
06/30/2023 Q2 -- -- -$26.14 -$6.00 -$20.14
03/31/2023 Q1 -- -- -$17.83 -$10.00 -$7.83
12/31/2022 Q4 -- -- -$128.00 -$16.00 -$112.00
09/30/2022 Q3 -- -- -$110.36 -$42.00 -$68.36
06/30/2022 Q2 -- -- -$91.98 -$58.50 -$33.48
03/31/2022 Q1 -- -- -$81.00 -- --
12/31/2021 Q4 -- -- -$75.00 -- --
09/30/2021 Q3 -- -- -$54.00 -- --
06/30/2021 Q2 -- -- -$12.00 -- --
03/31/2021 Q1 -- -- -$138.00 -- --
12/31/2020 Q4 -- -- -$175.00 -- --
09/30/2020 Q3 -- -- -$525.00 -- --
06/30/2020 Q2 -- -- -$300.00 -- --
03/31/2020 Q1 -- -- -$475.00 -- --
12/31/2019 Q4 -- -- -$325.00 -- --
09/30/2019 Q3 -- -- -$625.00 -- --
06/30/2019 Q2 -- -- -$450.00 -- --
03/31/2019 Q1 -- -- -$575.00 -- --
12/31/2018 Q4 -- -- -$825.00 -- --
09/30/2018 Q3 -- -- -$575.00 -- --
06/30/2018 Q2 -- -- -$600.00 -- --
03/31/2018 Q1 -- -- -$625.00 -- --
12/31/2017 Q4 -- -- -$525.00 -- --
09/30/2017 Q3 -- -- -$750.00 -- --
06/30/2017 Q2 -- -- -$1,525.00 -- --
03/31/2017 Q1 -- -- -$750.00 -- --
12/31/2016 Q4 -- -- -$821.36 -- --
09/30/2016 Q3 -- -- -$1,056.03 -- --
06/30/2016 Q2 -- -- -$704.02 -- --
03/31/2016 Q1 -- -- -$821.36 -- --
12/31/2015 Q4 -- -- -$469.35 -- --
09/30/2015 Q3 -- -- -$1,056.03 -- --
06/30/2015 Q2 -- -- -$1,408.05 -- --

Biolase Earnings Questions

  • How Much did Biolase Generate in Revenue Last Quarter?

    Biolase reported $10.9M worth of top line sales in its most recent quarter.

  • Did Biolase Beat Earnings Last Quarter?

    Biolase announced earnings per share of -$0.04 which represents a miss of analyst forecast a -- per share.

  • Is Biolase Profitable?

    Biolase reported $4.4M that represents $0.12 per share over the last quarter.

  • What is the Analyst Consensus for Biolase EPS Next Year?

    Biolase's earnings are forecast to decrease from -$29.44 per share to -$9.63 per share next year representing a decrease of -99.22%.

  • When is Biolase's Earnings Date?

    Biolase's next earnings date is April 4, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 19.56% over the past day.

Sell
16
PCVX alert for Apr 1

Vaxcyte [PCVX] is down 14.62% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 4.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock